Literature DB >> 24700324

Isolation of murine natural killer cells.

Melissa A Pak-Wittel1, Sytse J Piersma1, Beatrice F Plougastel1, Jennifer Poursine-Laurent1, Wayne M Yokoyama1,2.   

Abstract

This unit describes the isolation of natural killer (NK) cells from mouse spleen. The basic protocol describes a method for preparing a highly purified NK cell population from mouse spleen by depletion of contaminating cells with selected monoclonal antibodies (MAbs) and magnetic separation. There are several advantages to this negative selection process. One of these is that the NK cells are not coated with antibody and, therefore, are not at risk of functional perturbation by antibody cross-linking. Additionally, negative selection provides a way to isolate diverse subpopulations of NK cells without selectively purifying a specific subpopulation. Following enrichment, NK cell purity can be assessed by cell surface phenotype using flow cytometry.
Copyright © 2014 John Wiley & Sons, Inc.

Entities:  

Keywords:  cell isolation; immunology; innate immunity; magnetic separation

Mesh:

Substances:

Year:  2014        PMID: 24700324     DOI: 10.1002/0471142735.im0322s105

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  3 in total

1.  Differential regulation of transcription factor T-bet induction during NK cell development and T helper-1 cell differentiation.

Authors:  Difeng Fang; Kairong Cui; Yaqiang Cao; Mingzhu Zheng; Takeshi Kawabe; Gangqing Hu; Jaspal S Khillan; Dan Li; Chao Zhong; Dragana Jankovic; Alan Sher; Keji Zhao; Jinfang Zhu
Journal:  Immunity       Date:  2022-04-04       Impact factor: 43.474

2.  The PD-1/B7-H1 pathway modulates the natural killer cells versus mouse glioma stem cells.

Authors:  Bo Yuan Huang; Yi Ping Zhan; Wen Jing Zong; Chun Jiang Yu; Jun Fa Li; Yan Ming Qu; Song Han
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

3.  Comparison of the purity and vitality of natural killer cells with different isolation kits.

Authors:  Guangchuan Wang; Guang Yu; Dongmei Wang; Shengnan Guo; Fengping Shan
Journal:  Exp Ther Med       Date:  2017-03-07       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.